Covid and Cancer

Welcome to the Precious Metals Bug Forums

Welcome to the PMBug forums - a community supported watering hole for folks interested in gold, silver, precious metals, sound money, investing, market and economic news, central bank monetary policies, politics and more.

Register a free account to join the discussions. When you register an account and log in, you may enjoy additional benefits including access to market data/charts and additional members only rooms (including one for trade/barter with the community).

Voodoo

Praying Mantis
GIM2 Refugee
Messages
4,185
Reaction score
3,109
Points
288
Location
Deep Underground Bunker
These would seem to have nothing in common, but yet, we have seen drugs that are effective on both. How could that possibly be?

Well that might both be caused in a major way by parasites.

 
My mom got 3 covid shots and/or boosters, then developed breast cancer @ 84 and currently under going treatment.

We believe ithe vaccines surpressed her immune system so much it made her much more susecptible to a disease.
 
What else does your body immune system take care of when Healthy? Parasites. I'm not sure if the whole ADE mechanism also effects parasite but a generally weakened system lets them go crazy.

I'd highly recommend at least trying to get her to add one of these meds to that "treatment". They are cheap with far fewer side effects.
 
My wife and I take ivermectin monthly since she got parasites.
 
I take 12mg of ivermectin if I ever get what feel like virus like symptoms and the problem is gone pretty much overnight .

During the Rona nonsense, the advice was 1x12mg a day for 5 days then one a week for 3 weeks .

Because we weigh ourselves in stones and pounds in Blighty, it’s easy to do the calc ands it’s 1mg per stone of body weight .

A friend currently working through kidney cancer is on 10 times the above recommended dosage as advised by a Canadian alt doctor along with a raft of other stuff.
 
And seeing that this thread is about treating cancers I offer a long winded but thorough report from my friend regarding his apparently successful treatment -

Extracted from his newsletter -




During this time my son spent many hours researching additional ways to help treat the cancer. Aside from the immediate hormone treatment I was given in hospital and early in December he contacted Dr William Makis, a Canadian Radiologist who provides individual protocols to help fight patients with cancer through various repurposed medicines like Ivermectin and Menbendazole accompanied with supplements like Melatonin. Dr Makis kindly accepted me as a patient and I was immediately put on high dosages of all three of these amongst other things.
In the last few days Dr Makis, put up this report on my progress on ‘X’. This can be read on the links below. A fuller explanation though is added below in this report
https://threadreaderapp.com/thread/1895800117204025810.html
https://x.com/MakisMD/status/1895800117204025810?t=TlJVNVcdDwO5ndJfWqdUWw&s=03

Ivermectin started at 1mg per kg body weight and 500mg per kg body weight for Menbendazole. Melatonin was started at 100mg a day. After the first month these amounts were increased. Also during these early days, my son had contacted RGCC International. This was at the suggestion of an American consultant whose time was also kindly paid for by a generous donor.

RGCC is an organisation that provides an advanced cancer diagnostics test that suggests both conventional and alternative treatments based on the blood work and interaction with these compounds with the cancer cells within their labs. Their report opened up a variety of medications and supplements that we would have not known to have a positive effect. Some of them were not cheap but with the fund going well, we were able to take that route. One of which is a potent form of Astaxanthin called Valasta which has incredible testimonials for many different illnesses and ailments.

You may be familiar with the German doctor and Nobel prize winner Otto Warburg. In the 1920’s he observed the Warburg effect, where most cancers prefer to use aerobic Glycolysis, the process of using glucose in the presence of oxygen, even when there's enough oxygen to fully metabolize it and lactic acid fermentation. It is a process that breaks down sugars to produce energy and lactic acid for energy generation rather than the mechanisms used by non-cancerous cells.

We have learned that some cancers, such as prostate cancer, can switch metabolic pathways to enhance survival. When glucose is low, these cancer cells can shift to the oxidative phosphorylation (OXPHOS) pathway, using lipids (fatty acids), glutamine, lactate, or acetate as fuel, a process that occurs inside the mitochondria.

Professor Thomas Seyfried, a specialist in biology, genetics, and biochemistry at Boston College, argues that cancer is primarily a metabolic disease rather than a genetic disorder, with the root cause lying in dysfunctional cellular energy metabolism. Since cancer thrives on glucose and glutamine, he recommends eliminating these from the diet through fasting and a ketogenic diet. However, while these methods may deprive cancer cells of their primary fuel sources, they can also starve all cells of ATP.

Initially, I believed that increasing oxygen levels through therapies like hyperbaric oxygen and red light therapy would help in my fight against cancer. However, I’ve come to realize that this approach is more complex. Oxygen can enhance OXPHOS, and tumours that rely on this pathway or angiogenesis may grow faster in oxygen-rich environments. A 2020 study found that exposure to high concentrations of oxygen increased reactive oxygen species (ROS) production, which could fuel cancer cell growth. The relationship between mitochondria and oxidative phosphorylation is critical for healthy cellular energy production, and it’s clear that having the right amount of oxygen—neither too much nor too little—is essential for optimal cellular function. Given these risks, I’ve opted against these therapies to avoid potentially exacerbating cancer growth.

That's not to say oxygen rich conditions can't help in the fight against cancer but it wasn't as risk I was willing to take and for those reasons we decided to stop the hyperbaric oxygen chamber and red light therapy in case we were doing more harm than good and for us to know whether the cancer is relying on the OXPHOS pathway before using these machines would require regular testing to ensure safety and that realistically wasn't an option for me and we didn't want to rely on the hope that it wasn't.

Something else we learned was that cancer cells have pump mechanisms that help reduce the effectiveness of treatments.

Cancer cells have efflux pumps. A protective mechanism that excretes compounds designed to destroy the cell and several supplements and repurposed medicines can inhibit these pump mechanisms to increase the duration of the compound within the cell. This enhances its efficacy to weaken and destroy the cancer.

Unfortunately, efflux pump inhibitors are currently not available under the NHS but hopefully will be in the near future.

Some of the supplements and medications listed below, recommended by Dr. Makis and RGCC, have been shown to inhibit these pumps.

The use of other repurposed drugs has been found to be highly effective in reducing the risk of cancer recurrence.

One of the main reasons for cancer recurrence after remission is that many treatments are unable to target and eliminate cancer stem cells. cancer stem cells (CSCs) are a small subpopulation of cells within a tumour that possess the ability to self-renew, differentiate, and drive tumour growth.

That these supplements and repurposed drugs are not being widely used is likely by design for financial reasons. But emerging research suggests that the combination of Ivermectin and Mebendazole has been shown to damage or destroy cancer stem cells in some patients which greatly decreases the chances of cancer returning

The blood results from RGCC identified many other potential medications/ supplements which they had found to be measurably successful with my cancer.
Below is my current supplement protocol that you may find of interest/ use.
 
Current Protocol (Dr Makis Recommendations)

  • Ivermectin – This seems to kill Cancer stem cells and stops excess ROS
  • Mebendazole – This seems to help prevent the formation of microtubules in cancer cells which are essential for its cell division. This then leads to cell death (Apoptosis). It also seems to stop new blood vessels to grow from the tumour (Angiogenesis) and it seems to kill off some cancers stem cells.
  • Milk Thistle
  • Melatonin -– This seems to increase the activity of the Killer T cells in the immune system that attack the cancer cells. It also seems to reduce to toxic side effects from chemotherapy
  • Black Seed Oil
  • Turkey Tail mushroom
  • Berberine
  • Allicin
  • Olive Leaf
Additional Supplements (From RGCC Report & Additional Efflux Pump Inhibitors from ChatGPT)

  • Valasta - This one is particularly interesting for Bone Cancers Valasta.net a highly potent and bioavailable form of astaxanthin that reduces ROS and can induce cancer cell death apoptosis amongst other things.
  • Indole-3-Carbinol
  • Reishi Mushrooms
  • Boswellia
  • Butyric Acid
  • Vitamin E
  • Quercetin
  • Cordyceps Mushrooms
  • Doxycycline – a repurposed antibiotic that can be used as an efflux pump inhibitor.
  • Apigenin
  • Resveratrol
  • Citrus Pectin
  • Artemisinin
  • Chaga Mushroom
Some of you may already know that the timing of supplements is also important, either with food if they are fat soluble or without if they are water soluble, some compliment each other whilst others fight for absorption. As you can imagine, with a list this long, taking them throughout the day can get overwhelming and without the help of ChatGPT. This helped to determine which one to take and when. Without that, it would have been a nightmare to find out.
 
Abstract

Background/aim: Drug repurposing offers a pathway to identify accessible, low-toxicity cancer therapies. Ivermectin and mebendazole demonstrate multi-target anticancer activity in preclinical models. This study evaluates real-world patient-reported outcomes, safety, and adherence in patients with cancer using this combination.

Patients and methods: We analyzed a prospective observational cohort of 197 patients with cancer prescribed ivermectin and mebendazole off-label via a U.S. telemedicine platform. Participants received compounded capsules (25 mg ivermectin, 250 mg mebendazole). Data were collected through standardized digital surveys at baseline and 6-month follow-up. A total of 122 participants (61.9%) completed follow-up. Primary outcomes included self-reported cancer status, adherence, and adverse events. Confidence intervals were calculated using the Wilson method, with dose-stratified analyses using Chi-square tests.

Results: The cohort had a mean age of 67 years with balanced sex distribution and diverse malignancies, most commonly prostate (27.9%) and breast (18.3%). Median time since diagnosis was 1.2 years, with 37.1% reporting active progression at baseline. At six months, adherence was high, with 86.9% completing the initial prescription and 66.4% remaining on therapy. The Clinical Benefit Ratio (CBR) was 84.4% (95% confidence interval=77.0-89.8%). At follow-up, 48.4% of participants reported tumor regression or no evidence of disease (32.8% NED; 15.6% regression), while 36.1% reported stable disease and 15.6% reported progression. Side effects, reported by 25.4%, were dose-dependent and predominantly mild and primarily gastrointestinal, with 93.6% continuing therapy after adjustment. Concurrent therapies reported included chemotherapy (27.9%), radiation (21.3%), surgery (19.7%), supplements (49.2%), and dietary modification (37.7%).

Conclusion: In this prospective real-world cohort of patients with cancer, ivermectin and mebendazole were associated with high rates of self-reported clinical benefit and favorable tolerability. These findings are hypothesis-generating and support the need for randomized controlled trials.


 
Back
Top Bottom